1,196
Views
42
CrossRef citations to date
0
Altmetric
Research Article

Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964–2003 followed up to the end of 2006

, , , , , & show all
Pages 694-712 | Received 08 Dec 2009, Accepted 14 Jan 2010, Published online: 21 May 2010

References

  • Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint Å, . NORDCAN: Cancer incidence, mortality and prevalence in the Nordic countries, Version 3.4. Association of Nordic Cancer Registries. Danish Cancer Society. 2009 Available from http://www.ancr.nu.
  • Hartge P, Wang SS, Bracci PM, Devesa SS, Holly EA. Non- Hodgkin lymphoma. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd. New York: Oxford University Press; 2006. 898–918.
  • Ekström-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma – a review. Acta Oncol 2006;45:258–71.
  • Mueller NE, Grufferman S. Hodgkin lymphoma. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd. New York: Oxford University Press; 2006. 872–97.
  • Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R; the EUROCARE Working Group. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45: 931–91.
  • Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, . Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries. APMIS Suppl. 1995;49:1–161.
  • Møller B, Fekjaer H, Hakulinen T, Tryggvadóttir L, Storm HH, Talbäck M . Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev 2002;11(Suppl 1):S1–S96.
  • Roos AJ, Baris D, Weiss NS, Herrington L. Multiple myeloma. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd. New York: Oxford University Press; 2006. 919–45.
  • Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, . Cancer incidence in five continents. IX, Lyon, France: IARC Scientific Publications 160; 2007.
  • Linet M, Devesa SS, Morgan GJ. The leukemias. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention 3rd. New York: Oxford University Press; 2006. 841–71.
  • Engholm G, Storm HH, Ferlay J, Christensen N, Bray F, Ólafsdóttir E, . NORDCAN: Cancer incidence and mortality in the Nordic countries Acta Oncol 2010.
  • Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up the end of 2006. Material and methods. Acta Oncol; 2010.
  • Brenner H, Rachet B. Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 2004;40:2494–501.
  • Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307–16.
  • Talbäck M, Rosén M, Stenbeck M, Dickman PW. Cancer patient survival in Sweden at the beginning of the third millennium—predictions using period analysis. Cancer Causes Control 2004;15:967–76.
  • Nordic Myelomatosis Study Group. Nordic reference programme on Myelomaosis diagnosis and treatment 2001. Cited 30.11.2009. Available from www.nordic-myeloma.org/content/dk/pdf/referenceprogrammer/referenceprogram_2001.pdf.
  • Smith A, Wisloff F, Samson D. Guide on the diagnostics and management of multiple myeloma 2005. Br J Haematol 2005;132:410–51.
  • Lund EM, Clemmensen IH, Storm HH, Engholm G. Survey of the Nordic Cancer Registries, Danish Cancer Society, Copenhagen 2000. Available from http://www.ncu.nu/ancr/pdf/survey.pdf 29-08-2009.
  • Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27–33.
  • Thygesen LC, Nielsen OJ, Johansen C. Trends in adult leukaemia incidence and survival in Denmark, 1943–2003. Cancer Causes Control 2009;20:1671–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.